Endothelial and platelet function alterations in HIV-infected patients

Thrombosis Research

Volumn 129, Issue 3, 2012, Pages 301-308

  Gresele, P ^a   Falcinelli, E ^a   Sebastiano, M ^a   Baldelli, F ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR; PROTEINASE INHIBITOR; RITONAVIR; STAVUDINE; ZIDOVUDINE;

CARDIOVASCULAR RISK; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FATTY ACID BLOOD LEVEL; HEART INFARCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INFECTION; ISCHEMIC HEART DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; THROMBOCYTE; THROMBOCYTE ACTIVATION; TRIACYLGLYCEROL BLOOD LEVEL; VENOUS THROMBOEMBOLISM;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; HIV; HIV INFECTIONS; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 84857782302     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.11.022     Document Type: Review

References (60)

1. A.S. Fauci The AIDS epidemic considerations for the 21st century N Engl J Med 341 1999 1046 1050 (Pubitemid 29451801)
2. R.J. Shattock, M. Warren, S. McCormack, and C.A. Hankins AIDS. Turning the tide against HIV Science 333 2011 42 43
3. A.S. Fauci HIV and AIDS: 20 years of science Nat Med 9 2003 839 843 (Pubitemid 36889923)
4. D. Klein, J.B. Hurley, C.P. Quesenberry, and S. Sidney Do protease inhibitors increase the risk of coronary heart disease in patients with HIV-1 infection J Acquir Immune Defic Syndr 30 2002 471 477
5. J.S. Currier, A. Taylor, F. Boyd, C.M. Dezii, H. Kawabata, and B. Burtcel Coronary heart disease in HIV-infected individuals J Acquir Immune Defic Syndr 33 2003 506 512 (Pubitemid 36886080)
6. C. Grunfeld, D.P. Kotler, R. Hamadeh, A. Tierney, J. Wang, and R.N. Pierson Hypertriglyceridemia in the acquired immunodeficiency syndrome Am J Med 86 1989 27 31
7. E.R. Feeney, and P.W. Mallon HIV and HAART-Associated Dyslipidemia Open Cardiovasc Med J 5 2011 49 63
8. J. Kim, M. Ruff, E. Karwatowska-Prokopczuk, L. Hunt, H. Ji, and C.B. Pert HIV envelope protein gp120 induces neuropeptide Y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis Regul Pept 75-76 1998 201 205 (Pubitemid 28477528)
9. J.T. Willerson, and P.M. Ridker Inflammation as a cardiovascular risk factor Circulation 109 Suppl. 1 2004 II2 II10
10. E.S. Ford, J.H. Greenwald, A.G. Richterman, A. Rupert, L. Dutcher, and Y. Badralmaa Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection AIDS 24 2010 1509 1517
11. N.T. Funderburg, E. Mayne, S.F. Sieg, R. Asaad, W. Jiang, and M. Kalinowska Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation Blood 115 2010 161 167
12. H. Mu, H. Chai, P.H. Lin, Q. Yao, and C. Chen Current update on HIV-associated vascular disease and endothelial dysfunction World J Surg 31 2007 632 643 (Pubitemid 46496230)
13. Strategies for Management of Antiretroviral Therapy/INSIGHT: D:A:D Study Group Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients AIDS 22 2008 F17 F24
14. DAD Study Group N. Friis-Møller, P. Reiss, C.A. Sabin, R. Weber, and A. Monforte Class of antiretroviral drugs and the risk of myocardial infarction N Engl J Med 356 2007 1723 1735 (Pubitemid 46658704)
15. M. Bibas, G. Biava, and A. Antinori HIV-Associated Venous Thromboembolism Mediterr J Hematol Infect Dis 3 2011 e2011030
16. S. Verma, and T.J. Anderson Fundamentals of endothelial function for the clinical cardiologist Circulation 105 2002 546 549 (Pubitemid 34123425)
17. P. Gresele, S. Momi, and R. Migliacci Endothelium, venous thromboembolism and ischaemic cardiovascular events Thromb Haemost 103 2010 56 61
18. P. Gresele, C. Cerletti, G. Guglielmini, P. Pignatelli, G. de Gaetano, and F. Violi Effects of resveratrol and other wine polyphenols on vascular function: an update J Nutr Biochem 22 2011 201 211
19. C.J. Boos, G.Y. Lip, and A.D. Blann Circulating endothelial cells in cardiovascular disease J Am Coll Cardiol 48 2006 1538 1547 (Pubitemid 44550075)
20. P. Gresele, E. Falcinelli, and S. Momi Potentiation and priming of platelet activation: a potential target for antiplatelet therapy Trends Pharmacol Sci 29 2008 352 360
21. S. Akar, M.A. Ozcan, H. Ateş, O. Gürler, I. Alacacioglu, and G.H. Ozsan Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease Clin Appl Thromb Hemost 12 2006 451 457 (Pubitemid 44359243)
22. E.I. Lev, C.L. Alviar, M.E. Arikan, B.P. Dave, J.F. Granada, and T. DeLao Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction Am Heart J 153 2007 41.e1-6.
23. K. Winther, G. Gleerup, and T. Hedner Enhanced risk of thromboembolic disease in hypertension from platelet hyperfunction and decreased fibrinolytic activity: has antihypertensive therapy any influence? J Cardiovasc Pharmacol 19 Suppl. 3 1992 S21 S24
24. M. Frossard, I. Fuchs, J.M. Leitner, K. Hsieh, M. Vlcek, and H. Losert Platelet function predicts myocardial damage in patients with acute myocardial infarction Circulation 110 2004 1392 1397 (Pubitemid 39238016)
25. S.E. Epstein, Y.F. Zhou, and J. Zhu Infection and atherosclerosis: emerging mechanistic paradigms Circulation 100 1999 e20 e28
26. G. Barbaro, and E.C. Klatt HIV infection and the cardiovascular system AIDS Rev 4 2002 93 103 (Pubitemid 34808784)
27. L. Teofili, M.G. Iachininoto, S. Capodimonti, C. Ucciferri, E.R. Nuzzolo, and M. Martini Endothelial progenitor cell trafficking in human immunodeficiency virus-infected persons AIDS 24 2010 2443 2450
28. E.F. da Silva, F.A. Fonseca, C.N. França, P.R. Ferreira, M.C. Izar, and R. Salomão Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapy AIDS 25 2011 1595 1601
29. D. Chi, J. Henry, J. Kelley, R. Thorpe, J.K. Smith, and G. Krishnaswamy The effects of HIV infection on endothelial function Endothelium 7 2000 223 242 (Pubitemid 32015782)
30. I. Nordøy, P. Aukrust, F. Müller, and S.S. Frøland Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections Clin Immunol Immunopathol 81 1996 16 21 (Pubitemid 26338242)
31. P. Galea, C. Vermot-Desroches, C. Le Contel, J. Wijdenes, and J.C. Chermann Circulating cell adhesion molecules in HIV-1-infected patients as indicator markers for AIDS progression Res Immunol 148 1997 109 117 (Pubitemid 27287153)
32. A. Solages, J.A. Vita, D.J. Thornton, J. Murray, T. Heeren, and D.E. Craven Endothelial function in HIV-infected persons Clin Infect Dis 42 2006 1325 1332
33. D. Duprez, and J. Cohen Arterial stiffness as a risk factor for coronary atherosclerosis Curr Atheroscler Rep 9 2007 139 144 (Pubitemid 47376985)
34. G. Schillaci, G.V. De Socio, G. Pucci, M.R. Mannarino, J. Helou, and M. Pirro Aortic stiffness in untreated adult patients with human immunodeficiency virus infection Hypertension 52 2008 308 313
35. D. Francisci, S. Giannini, F. Baldelli, M. Leone, B. Belfiori, and G. Guglielmini HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction AIDS 23 2009 589 596
36. K. Wolf, D.A. Tsakiris, R. Weber, P. Erb, M. Battegay, and H.I.V. Swiss Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1 J Infect Dis 185 2002 456 462 (Pubitemid 34142807)
37. F.J. Torriani, L. Komarow, R.A. Parker, B.R. Cotter, J.S. Currier, and M.P. Dube Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s J Am Coll Cardiol 52 2008 569 576
38. K. De Gaetano Donati, R. Rabagliati, M. Tumbarello, E. Tacconelli, C. Amore, and R. Cauda Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy AIDS 17 2003 765 768 (Pubitemid 36521088)
39. D.S. Zhong, X. Lu, B.S. Conklin, P.H. Lin, A.B. Lumsden, and Q. Yao HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells Arterioscler Thromb Vasc Biol 22 2002 1560e6
40. M.P. Dubé, J.M. Vanderluitgaren, C.M. Leffler, A.D. Baron, and H.O. Steinberg Effect of indinavir (IND) monotherapy on endothelial function in men without HIV infection Proceedings of the 9th Conference on Retroviruses and Opportunistic Infections, Seattle, USA 2002
41. J.H. Stein, M.A. Klein, J.L. Bellehumeur, P.E. McBride, D.A. Wiebe, and J.D. Otvos Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction Circulation 104 2001 257 262 (Pubitemid 32666944)
42. W. Chan, D. Sviridov, and A.M. Dart HIV, atherosclerosis and inflammation: implications for treatment J HIV Ther 14 2009 61 68
43. P.Y. Hsue, P.W. Hunt, Y. Wu, A. Schnell, J.E. Ho, and H. Hatano Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients AIDS 23 2009 2021 2027
44. D. Francisci, E. Falcinelli, B. Belfiori, E. Petito, T. Fierro, and F. Baldelli HIV infection-induced endothelial dysfunction is partially corrected by tenofovir but less by abacavir AIDS Patient Care and STDs 2011 25:567-9
45. A.S. Weyrich, and G.A. Zimmerman Platelets: signaling cells in the immune continuum Trends Immunol 25 2004 489 495 (Pubitemid 39490256)
46. D. Zucker-Franklin, S. Seremetis, and Z.Y. Zheng Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets Blood 75 1990 1920 1923 (Pubitemid 20180278)
47. T. Youssefian, A. Drouin, J.M. Massé, J. Guichard, and E.M. Cramer Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation Blood 99 2002 4021 4029 (Pubitemid 35332043)
48. A. Pugliese, A. Savarino, C. Cantamessa, and D. Torre Influence of fibronectin on HIV-1 infection and capability of binding to platelets Cell Biochem Funct 14 1996 291 296 (Pubitemid 26402157)
49. A. Scaradavou HIV-related thrombocytopenia Blood Rev 16 2002 73 76 (Pubitemid 34293560)
50. C. Chelucci, M. Federico, R. Guerriero, G. Mattia, I. Casella, and E. Pelosi Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturating megakaryocytes Blood 91 1998 1225 1234 (Pubitemid 28086875)
51. M. Marroni, P. Gresele, G. Landonio, A. Lazzarin, M. Coen, and R. Vezza Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial Ann Intern Med 121 1994 423 429
52. P.A. Holme, F. Muller, N.O. Solum, F. Brosstad, S.S. Froland, and P. Aukrust Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection FASEB J 12 1998 79 89
53. R. Ahmad, A. Iannello, S. Samarani, R. Morisset, E. Toma, and M. Grosley Contribution of platelet activation to plasma IL-18 concentrations in HIV-infected AIDS patients AIDS 20 2006 1907 1909 (Pubitemid 44358916)
54. E. Pretorius, H.M. Oberholzer, E. Smit, E. Steyn, S. Briedenhann, and C.R. Franz Ultrastructural changes in platelet aggregates of HIV patients: a scanning electron microscopy study Ultrastruct Pathol 32 2008 75 79 (Pubitemid 351882984)
55. V.F. Corrales-Medina, J. Simkins, J.A. Chirinos, J.A. Serpa, L.L. Horstman, and W. Jy Increased levels of platelet microparticles in HIV-infected patients with good response to highly active antiretroviral therapy J Acquir Immune Defic Syndr 54 2010 217 218
56. L. Landrø, T. Ueland, K. Otterdal, S.S. Frøland, and P. Aukrust Persistently raised plasma levels of platelet-derived inflammatory mediators in HIV-infected patients during highly active anti-retroviral therapy J Thromb Haemost 9 2011 1075 1077
57. M. Shechter, A. Shechter, H. Hod, P. Fefer, B. Shenkman, and N. Koren-Morag Brachial artery endothelial function predicts platelet function in control subjects and in patients with acute myocardial infarction Platelets Aug 9 2011 [Epub ahead of print]
58. C.S. Satchell, A.G. Cotter, E.F. O'Connor, A.J. Peace, A.F. Tedesco, and A. Clare Platelet function and HIV: a case-control study AIDS 24 2010 649 657
59. P. Baum, G. Kosikova, S. Galkina, C. Stoddart, E. Weiss, and P. Sullam Abacavir, a Competitive Inhibitor of Soluble Guanylyl Cyclase, Increases Platelet Reactivity 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, US 2010 717
60. D. Francisci, E. Falcinelli, B. Belfiori, E. Petito, T. Fierro, and A.M. Mezzasoma Possible role of platelet activation in the cardiovascular complications associated with HIV infection: differential effects of abacavir (ABC) versus tenofovir (TDF) J Thromb Haemost 9 Suppls.2 2011 799 P-TH-096